bioRxivCancer BiologyPreprint
CPT1a regulates the delivery of extracellular fatty acids for cardiolipin turnover in prostate cancer cells.
N. T. Santiappillai, M. F. Hakeem-Sanni, A. Withy, L. M. Butler, L.-E. Quek, A. J. Hoy
Abstract
Mitochondrial fatty acid oxidation (FAO) has been proposed to be a major bioenergetic pathway in prostate cancer. However, this concept fails to consider FAO relative to other mitochondrial substrates. Here, we found extracellular long-chain fatty acids (LCFAs), including palmitate, stearate, oleate, linoleate, linolenate, are minor sources of carbon entering the TCA cycle compared to glucose and glutamine in prostate cancer cells, despite being assimilated in the mitochondria as acyl-carnitines. In contrast, cardiolipins were a prominent LCFAs sink, with some species achieving greater than 50% 13C-labelling within 6 hours, suggesting high cardiolipin turnover using extracellular LCFAs. Knockdown of CPT1a, the rate-limiting enzyme of LCFA entry into mitochondria, reduced the incorporation of extracellular linoleate into cardiolipins. These results demonstrate that FAO is not a major input for the TCA cycle and provide evidence for an underappreciated role for CPT1a in regulating LCFAs entry into mitochondria for cardiolipin remodelling.
- organism: human
- assay: metabolomics
- research focus: metabolism & bioenergetics
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- CANCER-ASSOCIATED FIBROBLASTS PROMOTE PROSTATE CANCER MALIGNANCY VIA METABOLIC REWIRING AND MITOCHONDRIAL TRANSFER
L. Ippolito, A. Morandi, … E. Giannoni·bioRxiv·Feb 22, 2019
- ACSM1 and ACSM3 regulate prostate cancer fatty acid metabolism to promote tumour growth and constrain ferroptosis
R. Shrestha, Z. D. Nassar, … L. A. Selth·bioRxiv·Oct 13, 2022
- Suppression of de novo lipogenesis and dietary PUFA supplementation inhibit prostate cancer progression
Silvia Daniele Rodrigues, Caroline F. Ribeiro, … Massimo F. Loda·bioRxiv·Sep 21, 2026
- DECR1 is an androgen-repressed survival factor that regulates PUFA oxidation to protect prostate tumor cells from ferroptosis
Z. D. Nassar, C. Y. Mah, … L. M. Butler·bioRxiv·Dec 6, 2019
- TAp63-regulated oncogenic long non-coding RNA-8 ( TROLL-8 ) regulates human breast cancer progression through CPT1A-mediated fatty acid oxidation
Avani A. Deshpande, Marco Napoli, … Elsa Renee Flores·bioRxiv·Jun 15, 2026
- Lipidomic profiling of clinical prostate cancer reveals targetable alterations in lipid composition
L. M. Butler, C. Y. Mah, … J. V. Swinnen·bioRxiv·Oct 27, 2020